- Home
- BLFS vs BCSF Comparison
BLFS vs BCSF Comparison
Compare BLFS & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- BCSF
- Stock Information
- Founded
- BLFS 1987
- BCSF 2015
- Country
- BLFS United States
- BCSF United States
- Employees
- BLFS N/A
- BCSF N/A
- Industry
- BLFS Medical/Dental Instruments
- BCSF Finance/Investors Services
- Sector
- BLFS Health Care
- BCSF Finance
- Exchange
- BLFS Nasdaq
- BCSF Nasdaq
- Market Cap
- BLFS 1.2B
- BCSF 1.1B
- IPO Year
- BLFS 1989
- BCSF 2018
- Fundamental
- Price
- BLFS $26.14
- BCSF $17.36
- Analyst Decision
- BLFS Strong Buy
- BCSF Hold
- Analyst Count
- BLFS 7
- BCSF 4
- Target Price
- BLFS $29.43
- BCSF $16.75
- AVG Volume (30 Days)
- BLFS 277.1K
- BCSF 194.2K
- Earning Date
- BLFS 02-27-2025
- BCSF 02-25-2025
- Dividend Yield
- BLFS N/A
- BCSF 10.35%
- EPS Growth
- BLFS N/A
- BCSF N/A
- EPS
- BLFS N/A
- BCSF 1.99
- Revenue
- BLFS $146,957,000.00
- BCSF $294,257,000.00
- Revenue This Year
- BLFS N/A
- BCSF N/A
- Revenue Next Year
- BLFS N/A
- BCSF N/A
- P/E Ratio
- BLFS N/A
- BCSF $8.75
- Revenue Growth
- BLFS 16.40
- BCSF 3.17
- 52 Week Low
- BLFS $14.50
- BCSF $14.78
- 52 Week High
- BLFS $28.88
- BCSF $17.97
- Technical
- Relative Strength Index (RSI)
- BLFS 47.94
- BCSF 53.36
- Support Level
- BLFS $24.77
- BCSF $16.79
- Resistance Level
- BLFS $28.10
- BCSF $17.58
- Average True Range (ATR)
- BLFS 1.37
- BCSF 0.27
- MACD
- BLFS -0.11
- BCSF -0.02
- Stochastic Oscillator
- BLFS 39.48
- BCSF 48.31
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes, First Lien Senior Secured Loan, Preferred Equity, Equity Interest, and Second Lien Senior Secured Loan among others.